Health

Population Council and Duchesnay Announce New International License Agreement for ANNOVERA®

Today the Population Council and Duchesnay announce an exclusive license agreement to make ANNOVERA® (segesterone acetate and ethinyl estradiol vaginal system), the first and only contraceptive fully under a woman’s control to protect against unintended pregnancy for up to a year, available in Canada, Europe, Latin America, Asia and other territories. This agreement is another step […]

thaipr.net

1 ธ.ค. 63

European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations

Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition factor gene (MET) exon 14 (METex14) skipping alterations. With this validation, the application is complete, and […]

thaipr.net

27 พ.ย. 63

MedAlliance announces successful completion of enrolment in ISABELLA clinical trial for the treatment of failing AV fistulas in hemodialysis patients

MedAlliance has announced completion of patient enrolment in the ISABELLA Clinical Trial with SELUTION SLR™ 018 DEB (drug-eluting balloon) for the treatment of dysfunctional AV fistulas in end-stage renal failure patients undergoing hemodialysis. SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained release of drug, similar to a drug-eluting […]

thaipr.net

25 พ.ย. 63

INSIGHTEC Announces MR-guided Focused Ultrasound to Treat Essential Tremor Received Funding by National Health Service (NHS) England

INSIGHTEC®, a global healthcare company focused on the therapeutic power of acoustic energy, today announced that the National Health Service (NHS) England has approved funding for MR-guided Focused Ultrasound for the treatment of medication-refractory Essential Tremor patients from April 2021. The NHS England is the publicly funded healthcare system for England. Essential Tremor is a neurological […]

thaipr.net

25 พ.ย. 63

NPL and Cambridge Quantum Computing (CQC) collaborate in quantum computing

– NPL supports Cambridge Quantum Computing to accelerate R&D through to commercialisation of their novel quantum photonic products – Incubation and collaboration with pioneering companies helps drive innovation within UK quantum sector Scientists at the National Physical Laboratory (NPL) are working with Cambridge Quantum Computing (CQC) to accelerate research and development to support the commercialisation […]

thaipr.net

24 พ.ย. 63

OMRON Strengthens Engagement with AliveCor with Series E Investment, Reinforces Cross-company Alliance for Remote Cardiovascular Condition Management

OMRON Healthcare Co., Ltd. announced on November 24 additional investment into AliveCor by its parent company, OMRON Corporation, as part of $65 million series E funding for the leader in AI-based personal electrocardiogram (ECG) technology. OMRON led this round of investment, reinforcing the cross-company collaboration that began in 2017. The companies continue to build on […]

thaipr.net

24 พ.ย. 63

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center to host virtual international symposium on complex cardiac arrhythmias

– EPLive 2020, a two-day educational conference, uses live cases as primary teaching tool On December 3 and 4, 2020, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center will host its fifth international symposium on complex arrhythmias, EPLive 2020. This year’s event will be held virtually due to the ongoing pandemic. EPLive […]

thaipr.net

24 พ.ย. 63

GemVax & KAEL reports further positive data from GV1001 Phase II Alzheimer’s Disease trial

GemVax & KAEL Co., Ltd.) a clinical stage company developing a novel peptide drug based on telomerase modification has released further positive data at the Korean Dementia Association’s Fall Conference from a Phase II trial in Alzheimer’s disease of lead candidate GV1001. Previously the company announced GV1001 was well tolerated and safe and the primary […]

thaipr.net

24 พ.ย. 63
1 … 132 133 134 135

Copyright © 2026 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.